Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China
This protocol was developed to conduct population-wide surveillance of the bivalent HPV-16/18-AS04-adjuvanted human papillomavirus (HPV) vaccine in terms of uptake and safety outcomes including potential immune-mediated diseases (pIMDs) and pregnancy-related outcomes in China. The study will use ele...
मुख्य लेखकों: | , , , , , , , , , , , , , , |
---|---|
स्वरूप: | लेख |
भाषा: | English |
प्रकाशित: |
Taylor & Francis Group
2024-12-01
|
श्रृंखला: | Human Vaccines & Immunotherapeutics |
विषय: | |
ऑनलाइन पहुंच: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2378535 |